FDX
36
-4
WDC
41
-2
HON
65
-2
V
60
-6
FLS
73
-2
ETR
68
3
SRE
63
-3
WAT
47
5
APA
21
2
OXY
40
3
TGNA
53
2
JPM
63
-4
CSX
51
-2
NAVI
41
-3
IBM
54
4
KR
34
-3
CSCO
63
2
NWSA
62
2
FMC
31
5
DHR
35
3
FDX
36
-4
WDC
41
-2
HON
65
-2
V
60
-6
FLS
73
-2
ETR
68
3
SRE
63
-3
WAT
47
5
APA
21
2
OXY
40
3
TGNA
53
2
JPM
63
-4
CSX
51
-2
NAVI
41
-3
IBM
54
4
KR
34
-3
CSCO
63
2
NWSA
62
2
FMC
31
5
DHR
35
3
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
32

CHGCY
Chugai Pharmaceutical

Last Price:
20.66
Seasonality Move:
5.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $749.99M
Price / Cash Flow: 28.52
Annual Sales: $3.31
Price / Book: 6.33

Profitability

EPS (TTM): 0.78200
Net Income (TTM): $2.57B
Gross Margin: $4.98B
Return on Equity: 21.98%
Return on Assets: 20.1%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCY is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.02

Price-to-Earnings

Trailing P/E Ratio: 29.72
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Sell
32
Chugai Pharmaceutical (CHGCY) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?